意大利科学联盟立场声明解读：药物审查和处方精简

Multimorbidity often leads to polypharmacyincreasing the risk of drug interactions and adverse drug reactions. Medication review and deprescribing are crucial strategies for improving therapeutic regimensaiming to enhance patients' overall health and quality of life through reviewing and reducing inappropriate medication use. In March 2024the Italian Scientific Consortium issued a position statement on medication review and deprescribingoutlining their key elementsmethodsavailable toolsand clinical value. Based on an analysis of this statementthis article introduces the concepts and objectives of medication review and deprescribing. It elaborates on the main processes from four aspectscomprehensive medication history reviewmedication therapy assessmentmultidisciplinary medication therapy planningand follow-up. The article reviews implementation outcomes across different healthcare settingsanalyzes challenges and coping strategies in Chinaand aims to provide theoretical support for promoting medication review and deprescribing by clinicians for their patients.